ReviewBiomedicines2021

Monoclonal Antibodies Targeting Alarmins: A New Perspective for Biological Therapies of Severe Asthma.

Corrado Pelaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.